Pfizer, Inc. (PFE) Tops Q1 EPS by 2c; Cuts FY12 Outlook
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $26.32 +0.23%
Revenue Growth %: -23.7%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
SFST, VLTO, CLIR, More
Revenue Growth %: -23.7%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Pfizer, Inc. (NYSE: PFE) reported Q1 EPS of $0.58, $0.02 better than the analyst estimate of $0.56. Revenue for the quarter came in at $15.4 billion versus the consensus estimate of $15.47 billion.
Sees FY12 adj-EPS of $2.14-$2.24 on sales of $58-$60 billion. The Street is currently expecting FY12 EPS of $2.26 on sales of $62.14 billion. Pfizer had previously guided FY12 adj-EPS to $2.20-$2.30 on sales of $60.5-$62.5 billion.
For earnings history and earnings-related data on Pfizer, Inc. (PFE) click here.
Sees FY12 adj-EPS of $2.14-$2.24 on sales of $58-$60 billion. The Street is currently expecting FY12 EPS of $2.26 on sales of $62.14 billion. Pfizer had previously guided FY12 adj-EPS to $2.20-$2.30 on sales of $60.5-$62.5 billion.
For earnings history and earnings-related data on Pfizer, Inc. (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Enova International (ENVA) Tops Q1 EPS by 19c
- Bank of N.T. Butterfield & Son (NTB) Tops Q1 EPS by 20c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Guidance, Hot ListRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
